Effect of Sibutramine on Weight Reduction in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

被引：0
|
作者：
Lindholm, Asa [1 ]
Bixo, Marie
Bjorn, Inger
Wolner-Hanssen, Pal
Eliasson, Mats
Larsson, Anders
Johnson, Owe
Poromaa, Inger Sundstrom
机构：
[1] Sunderby Hosp, Dept Obstet & Gynecol, Lulea, Sweden
来源：
OBSTETRICAL & GYNECOLOGICAL SURVEY | 2008年 / 63卷 / 11期
关键词：
D O I：
10.1097/01.ogx.0000334737.50486.4a
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：707 / 709
页数：3
相关论文
共 50 条
  • [1] Effect of sibutramine on weight reduction in women with polycystic ovary syndrome:: a randomized, double-blind, placebo-controlled trial
    Lindholm, Asa
    Bixo, Marie
    Bjorn, Inger
    Wolner-Hanssen, Pal
    Eliasson, Mats
    Larsson, Anders
    Johnson, Owe
    Poromaa, Inger Sundstrom
    [J]. FERTILITY AND STERILITY, 2008, 89 (05) : 1221 - 1228
  • [2] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    [J]. OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [3] Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial
    Banaszewska, Beata
    Wrotynska-Barczynska, Joanna
    Spaczynski, Robert Z.
    Pawelczyk, Leszek
    Duleba, Antoni J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (11): : 4322 - 4328
  • [4] Metabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
    Jamilian, M.
    [J]. CLINICAL ENDOCRINOLOGY, 2024, 100 (06) : 593 - 593
  • [5] Early effects of metformin in women with polycystic ovary syndrome: A prospective randomized, double-blind, placebo-controlled trial
    Eisenhardt, S
    Schwarzmann, N
    Henschel, V
    Germeyer, A
    von Wolff, M
    Hamann, A
    Strowitzki, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03): : 946 - 952
  • [6] Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
    Jamilian, Mehri
    Razavi, Maryamalsadat
    Kashan, Zohreh Fakhrie
    Ghandi, Yasser
    Bagherian, Tayebeh
    Asemi, Zatollah
    [J]. CLINICAL ENDOCRINOLOGY, 2015, 82 (06) : 885 - 891
  • [7] The Effect of Atorvastatin in Patients with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Study
    Sathyapalan, Thozhukat
    Kilpatrick, Eric S.
    Coady, Anne-Marie
    Atkin, Stephen L.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01): : 103 - 108
  • [8] Baseline Characteristics of the Participants of a Randomized, Double-Blind, Placebo-Controlled Trial of Atorvastatin for the Treatment of Women With Polycystic Ovary Syndrome
    Raja-Khan, Nazia
    Legro, Richard S.
    [J]. JOURNAL OF WOMENS HEALTH, 2008, 17 (08) : 1241 - 1241
  • [9] Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial
    Mehri Jamilian
    Fatemeh Foroozanfard
    Fereshteh Bahmani
    Rezvan Talaee
    Mahshid Monavari
    Zatollah Asemi
    [J]. Biological Trace Element Research, 2016, 170 : 271 - 278
  • [10] The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
    Ghanei, Nila
    Rezaei, Nima
    Amiri, Ghorban Ali
    Zayeri, Farid
    Makki, Golbou
    Nasseri, Esmat
    [J]. JOURNAL OF FUNCTIONAL FOODS, 2018, 42 : 306 - 311
12345